Skip to content

Examining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension

Examining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05520411
Enrollment
25
Registered
2022-08-29
Start date
2022-07-01
Completion date
2023-01-15
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bloating, Stomach Distended

Keywords

digestion, bloating

Brief summary

Flatter Me is a product that includes digestive enzymes in a way to support digestion of macronutrients and their constituents and provides herbs traditionally used for digestive health support. This trial aims to test Flatter Me against a placebo pill to examine differences in both subjective outcomes (feelings of bloating and indigestion) and changes in waist circumference (abdominal distension) after eating a test meal.

Interventions

DIETARY_SUPPLEMENTHUM Flatter Me

Proprietary Enzyme Blend: Protease 3.0 Protease 4.5 Protease 6.0 Neutral Bacterial Protease Peptidase Bromelain Papain Lipase Amylase Glucoamylase Alpha-galactosidase Invertase Diastase Hemicellulase + Cellulase Beta-Glucanase Phytase Lactase Ginger Root Fennel Seed Peppermint Leaf

Sponsors

Citruslabs
CollaboratorINDUSTRY
HUM Nutrition, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Self Report bloating or stomach distension at least once per day after eating

Exclusion criteria

* Females who are pregnant or breastfeeding * Currently taking any prescribed medication meant to treat gut health * Currently taking any medication for fluid balance (i.e., Aldactone) * Currently suffers from any pre-existing condition that would prevent them from adhering to the protocol. * Currently suffers from any pre-existing condition that would prevent them from consuming cheese pizza. * Use of an antibiotic in the previous 3 months. * Taking an iron supplement with \> 65mg of iron in the last week. * Diagnosed with any of IBS, chronic constipation, GERD, Crohn's Disease, ulcerative colitis, celiac disease, liver disease, kidney disease, heart failure. * Lactose Allergy or Intolerance * Any food allergies * Current smoker * Wears dentures

Design outcomes

Primary

MeasureTime frameDescription
Perceived Changes in Bloating and Stomach Distention1 WeekQuestionnaires will be administered to participants at multiple time points before and after eating a test meal. Symptom severity is rated on a scale of 0 (None) to 4 (Extremely Severe)

Secondary

MeasureTime frameDescription
Visible changes in stomach distension.1 weekParticipants will have their waist measured at multiple time points while in the lab

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026